Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT00749203

Organisation Name: Icahn School of Medicine at Mount Sinai

Overal Status: Completed

Start Date: January 2009

Last Update: February 14, 2018

Lead Sponsor: Dennis Charney

Brief Summary: The objective of the proposed study is to test if a single IV dose of ketamine (0.5 mg/kg) decreases symptoms of PTSD.

Conditions:
  • Stress Disorders, Post-Traumatic
  • PTSD
  • Depression
  • Anxiety Disorder


Total execution time in seconds: 0.25246500968933